Atrion Corp (ATRI.OQ)

ATRI.OQ

About

Atrion Corporation (Atrion), and its subsidiaries, develop and manufacture products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. During the year ended December 31, 2011, the Company’s fluid delivery products accounted for 38% of... (more)

Buy/Sell

No analyst recommendations are available for ATRI.OQ.

» Analyst Consensus

Overall

Beta:	0.76
Market Cap (Mil.):	$421.86
Shares Outstanding (Mil.):	2.02
Dividend:	0.56
Yield (%):	1.07

Financials

	ATRI.OQ	Industry	Sector
P/E (TTM):	17.91	30.13	34.44
EPS (TTM):	11.69	--	--
ROI:	15.73	10.43	18.54
ROE:	17.29	13.41	19.38

Latest News about ATRI.OQ

» More ATRI.OQ News

Competitors

	Price	Change
Alcon, Inc. (ACL.N)	--	--
STAAR Surgical Company (STAA.OQ)	$8.64	+0.04
Baxter International Inc. (BAX.N)	$72.94	+1.09
Henry Schein, Inc. (HSIC.OQ)	$95.38	+0.03
CareFusion Corporation (CFN.N)	$34.36	+0.67

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Atrion Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
Thomson Reuters Stock Report - ATRION CORPORATION (ATRI-O) Provider: Thomson Reuters Stock Report	$25.00 Buy
Atrion Corp Provider: S&P Capital IQ Quantitative Report	$46.00 Buy
ATRION CORPORATION (ATRI) 12-months forecast Provider: Pechala's Reports	$15.00 Buy
Validea Guru Analysis Report for ATRI. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. Provider: Validea	$12.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Stocks
Stock Screener
Market Data
Healthcare
Medical Equipment / Supplies / Distribution

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.